Type i interferon suppresses de novo virus-specific CD4 Th1 immunity during an established persistent viral infection

Proceedings of the National Academy of Sciences of the United States of America

Volumn 111, Issue 20, 2014, Pages 7409-7414

  Osokine, Ivan ^a,b   Snell, Laura M ^a,b   Cunningham, Cameron R ^a,b   Yamada, Douglas H ^a,b   Wilson, Elizabeth B ^a,b   Elsaesser, Heidi J ^a,b   De La Torre, Juan Carlos ^c   Brooks, David ^a,b  

^a Immunology and Molecular Genetics   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERFERON;

ANIMAL CELL; ARTICLE; B LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL DIFFERENTIATION; CELL SPECIFICITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; HELPER CELL; IMMUNOREGULATION; MOUSE; NONHUMAN; PERSISTENT INFECTION; PRIORITY JOURNAL; TH1 CELL; TISSUE DISTRIBUTION; VIRUS IMMUNITY; VIRUS INFECTION;

IMMUNOSUPPRESSION; LCMV;

ANIMALS; ARENAVIRIDAE INFECTIONS; B-LYMPHOCYTES; CD4-POSITIVE T-LYMPHOCYTES; CELL DIFFERENTIATION; GENE EXPRESSION REGULATION; IMMUNOSUPPRESSION; INTERFERON TYPE I; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; RECEPTORS, INTERFERON; SIGNAL TRANSDUCTION; TH1 CELLS; TISSUE DISTRIBUTION;

EID: 84901008927     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1401662111     Document Type: Article

References (41)

1. Ng CT, Snell LM, Brooks DG, Oldstone MB (2013) Networking at the level of host immunity: Immune cell interactions during persistent viral infections. Cell Host Microbe 13(6):652-664.
2. Crotty S (2011) Follicular helper CD4 T cells (TFH). Annu Rev Immunol 29:621-663.
3. Fahey LM, et al. (2011) Viral persistence redirects CD4 T cell differentiation toward T follicular helper cells. J Exp Med 208(5):987-999.
4. Szabo SJ, Sullivan BM, Peng SL, Glimcher LH (2003) Molecular mechanisms regulating Th1 immune responses. Annu Rev Immunol 21:713-758.
5. Aubert RD, et al. (2011) Antigen-specific CD4 T-cell help rescues exhausted CD8 T cells during chronic viral infection. Proc Natl Acad Sci USA 108(52):21182-21187.
6. Lin E, et al. (2010) Heterogeneity among viral antigen-specific CD4+ T cells and their de novo recruitment during persistent polyomavirus infection. J Immunol 185(3): 1692-1700.
7. Wilson EB, et al. (2012) Emergence of distinct multiarmed immunoregulatory antigenpresenting cells during persistent viral infection. Cell Host Microbe 11(5):481-491.
8. Moir S, Chun TW, Fauci AS (2011) Pathogenic mechanisms of HIV disease. Annu Rev Pathol 6:223-248.
9. Petrovic D, Dempsey E, Doherty DG, Kelleher D, Long A (2012) Hepatitis C virus-T-cell responses and viral escape mutations. Eur J Immunol 42(1):17-26.
10. Kitchen SG, Zack JA (2011) Stem cell-based approaches to treating HIV infection. Curr Opin HIV AIDS 6(1):68-73.
11. Ahmed R, Salmi A, Butler LD, Chiller JM, Oldstone MB (1984) Selection of genetic variants of lymphocytic choriomeningitis virus in spleens of persistently infected mice. Role in suppression of cytotoxic T lymphocyte response and viral persistence. J Exp Med 160(2):521-540.
12. Fahey LM, Brooks DG (2010) Opposing positive and negative regulation of T cell activity during viral persistence. Curr Opin Immunol 22(3):348-354.
13. Brooks DG, Teyton L, Oldstone MB, McGavern DB (2005) Intrinsic functional dysregulation of CD4 T cells occurs rapidly following persistent viral infection. J Virol 79(16):10514-10527.
14. Johnston RJ, et al. (2009) Bcl6 and Blimp-1 are reciprocal and antagonistic regulators of T follicular helper cell differentiation. Science 325(5943):1006-1010.
15. Probst HC, van den Broek M (2005) Priming of CTLs by lymphocytic choriomeningitis virus depends on dendritic cells. J Immunol 174(7):3920-3924.
16. Harker JA, Lewis GM, Mack L, Zuniga EI (2011) Late interleukin-6 escalates T follicular helper cell responses and controls a chronic viral infection. Science 334(6057):825-829.
17. Cucak H, Yrlid U, Reizis B, Kalinke U, Johansson-Lindbom B (2009) Type I interferon signaling in dendritic cells stimulates the development of lymph-node-resident T follicular helper cells. Immunity 31(3):491-501.
18. Hale JS, et al. (2013) Distinct memory CD4+ T cells with commitment to T follicular helper- and T helper 1-cell lineages are generated after acute viral infection. Immunity 38(4):805-817.
19. Hangartner L, et al. (2003) Antiviral immune responses in gene-targeted mice expressing the immunoglobulin heavy chain of virus-neutralizing antibodies. Proc Natl Acad Sci USA 100(22):12883-12888.
20. Hangartner L, et al. (2006) Nonneutralizing antibodies binding to the surface glycoprotein of lymphocytic choriomeningitis virus reduce early virus spread. J Exp Med 203(8):2033-2042.
21. Teijaro JR, et al. (2013) Persistent LCMV infection is controlled by blockade of type I interferon signaling. Science 340(6129):207-211.
22. Wilson EB, et al. (2013) Blockade of chronic type I interferon signaling to control persistent LCMV infection. Science 340(6129):202-207.
23. Wilson EB, Brooks DG (2013) Decoding the complexity of type I interferon to treat persistent viral infections. Trends Microbiol 21(12):634-640.
24. Fousteri G, et al. (2011) Increased memory conversion of nave CD8 T cells activated during late phases of acute virus infection due to decreased cumulative antigen exposure. PLoS One 6(1):e14502.
25. Mueller SN, et al. (2007) Regulation of homeostatic chemokine expression and cell trafficking during immune responses. Science 317(5838):670-674.
26. Vezys V, et al. (2006) Continuous recruitment of naive T cells contributes to heterogeneity of antiviral CD8 T cells during persistent infection. J Exp Med 203(10):2263-2269.
27. Marshall HD, Urban SL, Welsh RM (2011) Virus-induced transient immune suppression and the inhibition of T cell proliferation by type I interferon. J Virol 85(12):5929-5939.
28. Welsh RM, Bahl K, Marshall HD, Urban SL (2012) Type 1 interferons and antiviral CD8 T-cell responses. PLoS Pathog 8(1):e1002352.
29. Hong JJ, Amancha PK, Rogers K, Ansari AA, Villinger F (2012) Spatial alterations between CD4+ T follicular helper, B, and CD8+ T cells during simian immunodeficiency virus infection: T/B cell homeostasis, activation, and potential mechanism for viral escape. J Immunol 188(7):3247-3256.
30. Lindqvist M, et al. (2012) Expansion of HIV-specific T follicular helper cells in chronic HIV infection. J Clin Invest 122(9):3271-3280.
31. Petrovas C, et al. (2012) CD4 T follicular helper cell dynamics during SIV infection. J Clin Invest 122(9):3281-3294.
32. Recher M, et al. (2004) Deliberate removal of T cell help improves virus-neutralizing antibody production. Nat Immunol 5(9):934-942.
33. Hangartner L, Zinkernagel RM, Hengartner H (2006) Antiviral antibody responses: The two extremes of a wide spectrum. Nat Rev Immunol 6(3):231-243.
34. Grakoui A, et al. (2003) HCV persistence and immune evasion in the absence of memory T cell help. Science 302(5645):659-662.
35. Thimme R, et al. (2001) Determinants of viral clearance and persistence during acute hepatitis C virus infection. J Exp Med 194(10):1395-1406.
36. Vingert B, et al. (2012) HIV controllers maintain a population of highly efficient Th1 effector cells in contrast to patients treated in the long term. J Virol 86(19):10661-10674.
37. Elsaesser H, Sauer K, Brooks DG (2009) IL-21 is required to control chronic viral infection. Science 324(5934):1569-1572.
38. Frhlich A, et al. (2009) IL-21R on T cells is critical for sustained functionality and control of chronic viral infection. Science 324(5934):1576-1580.
39. Yi JS, Du M, Zajac AJ (2009) A vital role for interleukin-21 in the control of a chronic viral infection. Science 324(5934):1572-1576.
40. Oxenius A, Bachmann MF, Zinkernagel RM, Hengartner H (1998) Virus-specific MHCclass II-restricted TCR-transgenic mice: Effects on humoral and cellular immune responses after viral infection. Eur J Immunol 28(1):390-400.
41. Brooks DG, McGavern DB, Oldstone MB (2006) Reprogramming of antiviral T cells prevents inactivation and restores T cell activity during persistent viral infection. J Clin Invest 116(6):1675-1685.